How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume -, Issue -, Pages 1-4
Publisher
Informa UK Limited
Online
2023-09-26
DOI
10.1080/14728214.2023.2264182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane
- (2022) Paula R. Pohlmann et al. BREAST CANCER RESEARCH AND TREATMENT
- Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
- (2022) Arlene Chan et al. BREAST
- Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
- (2020) Gianluca Ianiro et al. Nature Communications
- The pros, cons, and many unknowns of probiotics
- (2019) Jotham Suez et al. NATURE MEDICINE
- A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer
- (2019) Liyana Zaharuddin et al. BMC GASTROENTEROLOGY
- Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines
- (2019) Joanne M. Bowen et al. SUPPORTIVE CARE IN CANCER
- Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines†
- (2018) P Bossi et al. ANNALS OF ONCOLOGY
- Risk and Safety of Probiotics
- (2015) Shira Doron et al. CLINICAL INFECTIOUS DISEASES
- Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
- (2015) Michal Mego et al. COMPLEMENTARY THERAPIES IN MEDICINE
- A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia
- (2014) Kenneth F. Bradstock et al. BRITISH JOURNAL OF HAEMATOLOGY
- A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan
- (2014) Bryan K. Kee et al. SUPPORTIVE CARE IN CANCER
- Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM
- (2013) A H E Herbers et al. BONE MARROW TRANSPLANTATION
- Evaluating the Patient With Diarrhea: A Case-Based Approach
- (2012) Seth Sweetser MAYO CLINIC PROCEEDINGS
- Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: A randomised double blinded, placebo controlled pilot study
- (2011) Nada Rotovnik Kozjek et al. CLINICAL NUTRITION
- Crofelemer, an Antisecretory Antidiarrheal Proanthocyanidin Oligomer Extracted from Croton lechleri, Targets Two Distinct Intestinal Chloride Channels
- (2009) L. Tradtrantip et al. MOLECULAR PHARMACOLOGY
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search